MEEDER ASSET MANAGEMENT INC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,0000.0%90
-18.9%
0.00%
Q2 2022$5,000
-44.4%
111
-16.5%
0.00%
Q1 2022$9,000
+50.0%
133
+25.5%
0.00%
Q3 2021$6,000
+50.0%
106
+11.6%
0.00%
Q2 2021$4,000
-42.9%
95
-29.6%
0.00%
Q1 2021$7,000
+16.7%
135
-6.2%
0.00%
-100.0%
Q4 2020$6,0000.0%144
+4.3%
0.00%
Q3 2020$6,000
+200.0%
138
+360.0%
0.00%
Q2 2020$2,000
-75.0%
30
-76.4%
0.00%
Q4 2019$8,000
-61.9%
127
-63.7%
0.00%
-100.0%
Q3 2019$21,000
-94.3%
350
-92.0%
0.00%
-96.2%
Q2 2019$368,000
+214.5%
4,358
+257.8%
0.03%
+188.9%
Q1 2019$117,000
-5.6%
1,218
-30.6%
0.01%
-18.2%
Q4 2018$124,000
-22.0%
1,755
-5.5%
0.01%
-8.3%
Q3 2018$159,000
-99.9%
1,857
-19.9%
0.01%
-47.8%
Q2 2018$268,541,000
+315830.6%
2,317
+123.4%
0.02%
+187.5%
Q1 2018$85,000
+28.8%
1,037
-7.7%
0.01%
+33.3%
Q4 2017$66,000
+46.7%
1,124
+18.3%
0.01%
+20.0%
Q3 2017$45,000
+650.0%
950
+512.9%
0.01%
+400.0%
Q2 2017$6,000
+200.0%
155
+124.6%
0.00%
Q1 2017$2,000690.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders